VT-501

N/A

Report date: 2025/01/26 16:03:54
NME

Base Information

Drug NameVT-501
Drug Alias NameFAS/TNF-alpha Inhibitor (Visus Therapeutics/Cella Therapeutics)VT-501
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSoluble Fas ligand inhibitorsTumor necrosis factor α inhibitors
TargetsTumor necrosis factor αSoluble Fas ligand
Therapy Area/IndicationsGeographic AtrophyMacular Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCella Therapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesCella Therapeutics LLCVisus Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsGeographic AtrophyMacular Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A